A1 Journal article – refereed
2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer – a randomised, phase 3 trial




Subtitle: a randomised, phase 3 trial
List of Authors: Pirkko-Liisa Kellokumpu-Lehtinen, Ulrika Harmenberg, Timo Joensuu, Ray McDermott, Petteri Hervonen, Claes Ginman, Marjaana Luukkaa, Paul Nyandoto, Akseli Hemminki, Sten Nilsson, John McCaffrey, Raija Asola, Taina Turpeenniemi-Hujanen, Fredrik Laestadius, Tiina Tasmuth, Katinka Sandberg, Maccon Keane, Ilari Lehtinen, Tiina Luukkaala, Heikki Joensuu, for the PROSTY study group
Publisher: The Lancet Publishing Group
Publication year: 2013
Journal: Lancet Oncology
Number in series: 2
Volume number: 14
Issue number: 2
Number of pages: 8
ISSN: 1470-2045
eISSN: 1474-5488


Last updated on 2019-21-08 at 23:10

Share link